Sign Out
Faverin tablets are contraindicated in combination with tizanidine and monoamine oxidase inhibitors (MAOIs) (see Interactions).
Treatment with Faverin can be initiated: Two weeks after discontinuation of an irreversible MAOI, or the following day after discontinuation of a reversible MAOI (e.g. moclobemide, linezolid).
At least one week should elapse between discontinuation of Faverin and initiation of therapy with any MAOI.
Faverin should not be used in combination with ramelteon (see Interactions).
Hypersensitivity to the active substance or to any of the excipients.
